Caution: JavaScript execution is disabled in your browser or for this website. You may not be able to answer all questions in this survey. Please, verify your browser parameters.

"Self-care of Patients with COVID-19 Using Cannabis" 1 Part : Acute Illness

Due to being highly infectious, the new pathogen - SARS-CoV – poses danger to everyone. To date, hardly any treatments are known that can alleviate the severity of the disease, shorten its course, support the healing process or slow down its progression. Therefore, some patients are choosing to use of cannabis in their self-care. The evidence of the therapeutic effects of cannabis (e.g. the anti-inflammatory, antibiotic, antispasmodic, bronchodilator-like and sedative actions) are accumulating but adverse effects with regards to lung function such as airway inflammation, symptoms of bronchitis, increased airway resistance and lung hyperinflation are also reported.   The aim of this survey is to collect your experience as a SARS-CoV patient who has used cannabis in self-care.

We can guarantee that your data will only be processed for the purpose of this study and will not be transmitted to third parties. The data will be deleted after the evaluation. The evaluation is absolutely anonymous. No inferences about your identity will be possible at any time.

SARS-CoV patients are defined for the purpose of this study as those who have tested positive and have either not developed any symptoms or show symptoms of any degree (from mild to severe). Should you belong to this group, we are asking you to complete this survey to the best of your knowledge. It will take you only about 5 minutes to complete. Information about the further course of your infection over time is also of interest in this study. In four weeks, you will invited again and another survey questionnaire will be posted to collect and evaluate your experience since the first survey questionnaire. 

Thank you for your participation in this survey. Only through your efforts will it be possible for us to support each other by sharing and analysing our experiences in  overcoming SARS-CoV

Prof. Dr. phil. habil. Gundula Persch / Drugs and Social Work / PHONE +49 3461 46-2254 / E-MAIL/INTERNET gundula.barsch@hs-merseburg.de http://gundula-barsch.de  

ADDRESS Hochschule Merseburg Eberhard-Leibnitz-Straße 2 Department of Social Affairs, Media and Culture "Drugs and Social Work" 06217 Merseburg / Germany

Christoph Roßner / interdisciplinary hemp expert / E-MAIL/INTERNET cr@rossner-consulting.de www.rossner-consulting.de  

ADDRESS Christoph Rossner Ulmer Str. 11 87700 Memmingen / Germany


There are 12 questions in this survey.